Newman, J. E., Fitzgerald, O., Paul, R. C., & Chambers, G. M. (2019). Assisted Reproductive Technology in Australia and New Zealand 2017. National Perinatal Epidemiology and Statistics Unit. https://doi.org/10.26190/unsworks/30473
Newman JE, Fitzgerald O, Paul RC, Chambers GM. Assisted Reproductive Technology in Australia and New Zealand 2017. National Perinatal Epidemiology and Statistics Unit; 2019. doi:10.26190/unsworks/30473
Newman, Jade, et al. Assisted Reproductive Technology in Australia and New Zealand 2017. National Perinatal Epidemiology and Statistics Unit, 2019.
For EndNote, Zotero or Mendeley:
License
Open-access status not yet checked.
RRM Academy Synopsis
18% Of ART Cycles In Australia And New Zealand Ended In Live Delivery
This is the national report on fertility clinics in Australia and New Zealand, covering all 82,215 ART cycles from clinics in both countries in 2017. Fewer than 1 in 5 ART cycles ended in a live delivery. About 8 in 10 liveborn babies were single, full-term babies of normal weight.
Key Findings
In 2017, Australian and New Zealand clinics reported 82,215 ART cycles in total: 74,942 in Australia and 7,273 in New Zealand. This was more cycles than the year before.
Out of all 82,215 cycles that year, 18,860 (22.9%) led to a confirmed pregnancy, and 14,882 (18.1%) ended with the birth of at least one baby.
Leaving out cycles where every embryo was frozen for later use, 16.4% of all started fresh autologous cycles led to a baby being born. Among started thaw cycles the figure was 27.9%.
Live births per embryo transfer climbed from 23.6% in 2013 to 26.8% in 2017. Over the same five years, multiple-baby deliveries dropped from 5.6% to 3.6% of all deliveries.
Younger women had far higher success: those under 30 had a 38.5% chance of a baby per fresh embryo transfer, versus 1.4% for women over 44.
Interpretation
The registry records every ART cycle that clinics in Australia and New Zealand reported in 2017. The report does not test why any single cycle worked or did not. All clinics in both countries took part. The report counts most figures per cycle and does not track results per woman. One part follows one group of 15,530 women through repeat cycles starting in 2015. The report lists the cause of infertility for each cycle as the treating clinician reported it, with definitions that vary among clinics. The report does not compare ART with other ways to become pregnant.
RRM Context
This registry tracks outcomes of assisted reproductive technology (ART). ART works around the reproductive system instead of finding out why pregnancy is not happening. Restorative reproductive medicine takes the opposite approach: find the cause, then treat it. No registry this complete yet exists for restorative care.
Our editorial summary of this paper, not the article's abstract.
Key figures
Treatment activity, 2017
Measure
Value
Source
Total ART treatment cycles reported, Australia and New Zealand
82,215
Key results summary
ART treatment cycles reported in Australia
74,942
Key results summary
ART treatment cycles reported in New Zealand
7,273
Key results summary
Autologous cycles as a share of all ART treatments
94.1%
Key results summary
Autologous cycles that used frozen-thawed embryos or oocytes
38.5%
Key results summary
Patient characteristics, 2017
Measure
Value
Source
Average age of women undergoing autologous ART cycles
35.7 years
Patient age
Autologous-cycle women aged 40 or older
23.4%
Patient age
Pregnancy and birth outcomes, 2017
Measure
Value
Source
Clinical pregnancy rate per initiated ART cycle
22.9% (18,860)
Treatment outcomes
Live delivery rate per initiated ART cycle
18.1% (14,882)
Treatment outcomes
Clinical pregnancy rate per embryo transfer, all ART cycles
33.9%
Treatment outcomes
Live delivery rate per initiated autologous fresh cycle, excluding freeze-all cycles
16.4%
Treatment outcomes
Live delivery rate per embryo transfer, autologous fresh cycles
24.1%
Treatment outcomes
Live delivery rate per initiated autologous thaw cycle
27.9%
Treatment outcomes
Live delivery rate per embryo transfer, autologous thaw cycles
28.9%
Treatment outcomes
Age-stratified outcomes, 2017
Measure
Value
Source
Live delivery rate per embryo transfer, autologous fresh cycles, women under 30
38.5%
Age-stratified outcomes
Live delivery rate per embryo transfer, autologous thaw cycles, women under 30
33.1%
Age-stratified outcomes
Live delivery rate per embryo transfer, autologous fresh cycles, women over 44
1.4%
Age-stratified outcomes
Live delivery rate per embryo transfer, autologous thaw cycles, women over 44
10.6%
Age-stratified outcomes
Babies born and multiples, 2017
Measure
Value
Source
Total babies born following ART treatment
15,613
Babies born
Liveborn babies following ART treatment
15,405
Babies born
Full-term singleton babies of normal birthweight, share of ART babies born
80.2%
Babies born
Embryo transfer practice, five-year trend 2013 to 2017
Measure
Value
Source
Single embryo transfer rate, 2013 to 2017
76.3% to 89.4%
Multiple birth trends
Multiple births, five-year trend 2013 to 2017
Measure
Value
Source
ART multiple-delivery rate, 2013 to 2017
5.6% to 3.6%
Multiple birth trends
Five-year trend, live delivery rate per embryo transfer, 2013 to 2017
Measure
Value
Source
Live delivery rate per embryo transfer, 2013 to 2017
23.6% to 26.8%
Trends
Improvement in live delivery rate per embryo transfer, 2013 to 2017
13.6%
Trends
Our summary of the report's published figures, each citing its table, figure or section. The full report is at the publisher's link.
A global reference to national IVF registries (HFEA, RTAC, ANZARD, Q-IVF, CDC, DIR, JSOG, CARTR Plus, REDLARA, ESHRE EIM, ICMART) and the codes of practice that govern fertility clinics. What each measures, and what they miss.